Europe PMC

This website requires cookies, and the limited processing of your personal data in order to function. By using the site you are agreeing to this as outlined in our privacy notice and cookie policy.

A global view of pulmonary hypertension.

Author information

Affiliations

  • 1. Department of Respiratory Medicine, Hannover Medical School, Hannover, Germany; German Centre for Lung Research, Hannover, Germany.
      Authors
    • Hoeper MM 1
    (1 author)
  • 2. Service de Pneumologie, Hôpital Bicêtre (Assistance Publique-Hôpitaux de Paris), Inserm UMR-S 999, Université Paris Sud, Université Paris-Saclay, Le Kremlin-Bicêtre, Paris, France.
      Authors
    • Humbert M 2
    (1 author)
  • 3. Pulmonary Department, Heart Institute, University of São Paolo Medical School, São Paolo, Brazil.
      Authors
    • Souza R 3
    (1 author)
  • 4. Department of Pulmonary Medicine, Prince Sultan Medical Military City, Riyadh, Saudi Arabia.
      Authors
    • Idrees M 4
    (1 author)
  • 5. Departments of Medicine and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
      Authors
    • Kawut SM 5
    (1 author)
    • Show all (8)

ORCIDs linked to this article

The Lancet. Respiratory Medicine, 12 Mar 2016, 4(4):306-322
https://doi.org/10.1016/s2213-2600(15)00543-3 PMID: 26975810 

Review

Abstract 

Pulmonary hypertension is a substantial global health issue. All age groups are affected with rapidly growing importance in elderly people, particularly in countries with ageing populations. Present estimates suggest a pulmonary hypertension prevalence of about 1% of the global population, which increases up to 10% in individuals aged more than 65 years. In almost all parts of the world, left-sided heart and lung diseases have become the most frequent causes of pulmonary hypertension. About 80% of affected patients live in developing countries, where pulmonary hypertension is frequently associated with congenital heart disease and various infectious disorders, including schistosomiasis, HIV, and rheumatic heart disease. These forms of pulmonary hypertension occur predominantly in those younger than 65 years. Independently of the underlying disease, the development of pulmonary hypertension is associated with clinical deterioration and a substantially increased mortality risk. Global research efforts are needed to establish preventive strategies and treatments for the various types of pulmonary hypertension.

Full text links 

Read article at publisher's site: https://doi.org/10.1016/s2213-2600(15)00543-3

Citations & impact 

Impact metrics

342
Citations
Jump to Citations

Citations of article over time

Alternative metrics

Altmetric item for https://www.altmetric.com/details/6185519
Altmetric
Discover the attention surrounding your research
https://www.altmetric.com/details/6185519

Smart citations by scite.ai
Smart citations by scite.ai include citation statements extracted from the full text of the citing article. The number of the statements may be higher than the number of citations provided by EuropePMC if one paper cites another multiple times or lower if scite has not yet processed some of the citing articles.
Explore citation contexts and check if this article has been supported or disputed.
https://scite.ai/reports/10.1016/s2213-2600(15)00543-3

Supporting
Mentioning
Contrasting
6
495
0

Article citations

Go to all (342) article citations

Similar Articles 

To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.